Amanote Research
Register
Sign In
P2.03-22 OCT4andSOX2 Specific CTLs Plus PD-1 Inhibitor Had Synergistic Effect on Killing CSC and Treating Drug-Resistant Lung Cancer Mice
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1209
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
X. Zhang
F. Hu
X. Zheng
B. Zhang
H. Wang
G. Tao
J. Xu
Y. Zhang
B. Han
Publisher
Elsevier BV
Related search
New Drugs for Treating Drug Resistant HIV-1
Sexually Transmitted Infections
Dermatology
Infectious Diseases
P2.03-37 the Efficiency of Octamer-4 Specific Cytotoxic T Cells Induce by CD40-B Cells in Killing Lung Cancer Stem-Like Cells
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.03-06 Serum Syndechan-1 Levels in Patients With Nonsmall Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
Prostate Cancer
Cancer Research
Oncology
Urology
Cancer Immunotherapy: PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy (Adv. Mater. 22/2018)
Advanced Materials
Mechanics of Materials
Materials Science
Nanotechnology
Mechanical Engineering
Nanoscience
Structural Studies of a Rationally Selected Multi-Drug Resistant HIV-1 Protease Reveal Synergistic Effect of Distal Mutations on Flap Dynamics
PLoS ONE
Multidisciplinary
Synergistic Effect of Afatinib With Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
PLoS ONE
Multidisciplinary
Tim-3 Expression on PD-1+ HCV-specific Human CTLs Is Associated With Viral Persistence, and Its Blockade Restores Hepatocyte-Directed in Vitro Cytotoxicity
Journal of Clinical Investigation
Medicine
P2.03-21 Mechanistic Investigation of DRD1 in Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
